Literature DB >> 25519767

Modern Gamma Knife radiosurgery of vestibular schwannomas: treatment concept, volumetric tumor response, and functional results.

Samuel M Lipski1, Motohiro Hayashi, Mikhail Chernov, Marc Levivier, Yoshikazu Okada.   

Abstract

The objective of the present study was longitudinal evaluation of the volumetric tumor response and functional results after Gamma Knife radiosurgery of vestibular schwannomas, performed according to the modern standards of treatment. From October 2003 to September 2007, 133 consecutive patients with vestibular schwannomas were treated according to the concept of robotic Gamma Knife microradiosurgery, which is based on precise irradiation of the lesion, sparing adjacent structures, and delivery of the high radiation energy to the target. Multiple small-sized isocenters located within the border of the neoplasm were applied. The mean marginal dose was 11.5 Gy (range, 11-12 Gy). In total, 126 cases with a minimum posttreatment follow-up of 2 years (range, 2-7 years; median, 4 years) were analyzed. Temporary enlargement was noted in 25% of tumors at 6 months after radiosurgery. At 3 years of follow-up, tumor shrinkage, stabilization, and increase in volume were marked in 73%, 23%, and 4% of cases, respectively. All progressing lesions spontaneously stabilized later on and did not require additional management. In 3% of patients, transitory impairment of the facial nerve function was marked; however, neither its permanent dysfunction nor trigeminal neuropathy attributed to radiosurgery was noted. Impairment of hearing compared to its pretreatment level was revealed in 4%, 12%, 13%, and 16% of patients at 6 months, 1 year, 2 years, and 3 years after radiosurgery, respectively, and this trend was statistically significant (P = 0.0042). Overall, 77% of patients with serviceable hearing before treatment preserved it 3 years thereafter. In conclusion, modern Gamma Knife radiosurgery provides effective and safe management of vestibular schwannomas. Nevertheless, possible temporary tumor enlargement, delay of its growth arrest, transient dysfunction of the cranial nerves, and gradual deterioration of hearing after irradiation should be always taken into consideration.

Entities:  

Mesh:

Year:  2014        PMID: 25519767     DOI: 10.1007/s10143-014-0601-3

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  78 in total

1.  Gamma knife surgery for vestibular schwannoma: 10-year experience of 195 cases.

Authors:  Wen-Yuh Chung; Kang-Du Liu; Cheng-Ying Shiau; Hsiu-Mei Wu; Ling-Wei Wang; Wan-Yuo Guo; Donald Ming-Tak Ho; David Hung-Chi Pan
Journal:  J Neurosurg       Date:  2005-01       Impact factor: 5.115

2.  Low-dose radiosurgery for large vestibular schwannomas: long-term results of functional preservation.

Authors:  Hiroshi K Inoue
Journal:  J Neurosurg       Date:  2005-01       Impact factor: 5.115

Review 3.  Concept of robotic gamma knife microradiosurgery and results of its clinical application in benign skull base tumors.

Authors:  Motohiro Hayashi; Mikhail F Chernov; Noriko Tamura; Masahiro Izawa; Yoshihiro Muragaki; Hiroshi Iseki; Yoshikazu Okada; Pavel Ivanov; Jean Régis; Kintomo Takakura
Journal:  Acta Neurochir Suppl       Date:  2013

4.  Tumor-volume changes after radiosurgery for vestibular schwannoma: implications for follow-up MR imaging protocol.

Authors:  O W M Meijer; E J Weijmans; D L Knol; B J Slotman; F Barkhof; W P Vandertop; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-22       Impact factor: 3.825

5.  Use of apparent diffusion coefficients in evaluating the response of vestibular schwannomas to Gamma Knife surgery.

Authors:  Chun-Chao Chuang; Cheng-Siu Chang; Yu-Sheng Tyan; Keh-Shih Chuang; Hsien-Tang Tu; Chuan-Fu Huang
Journal:  J Neurosurg       Date:  2012-12       Impact factor: 5.115

6.  Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.

Authors:  Andrew M Baschnagel; Peter Y Chen; Dennis Bojrab; Daniel Pieper; Jack Kartush; Oksana Didyuk; Ilka C Naumann; Ann Maitz; Inga S Grills
Journal:  J Neurosurg       Date:  2012-12-07       Impact factor: 5.115

7.  Current treatment strategy for vestibular schwannoma: image-guided robotic microradiosurgery.

Authors:  Motohiro Hayashi; Taku Ochiai; Kotaro Nakaya; Mikhail Chernov; Noriko Tamura; Takashi Maruyama; Shoji Yomo; Masahiro Izawa; Tomokatsu Hori; Kintomo Takakura; Jean Regis
Journal:  J Neurosurg       Date:  2006-12       Impact factor: 5.115

Review 8.  Treatment of vestibular schwannomas. Why, when and how?

Authors:  E Myrseth; P-H Pedersen; P Møller; M Lund-Johansen
Journal:  Acta Neurochir (Wien)       Date:  2007-06-11       Impact factor: 2.216

9.  Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience.

Authors:  Bruce E Pollock
Journal:  Neurosurgery       Date:  2006-02       Impact factor: 4.654

10.  Transient expansion of vestibular schwannoma following stereotactic radiosurgery.

Authors:  Osamu Nagano; Yoshinori Higuchi; Toru Serizawa; Junichi Ono; Shinji Matsuda; Iwao Yamakami; Naokatsu Saeki
Journal:  J Neurosurg       Date:  2008-11       Impact factor: 5.115

View more
  4 in total

1.  Communicating hydrocephalus after radiosurgery for vestibular schwannomas: does technique matter? A systematic review and meta-analysis.

Authors:  Paolo De Sanctis; Sheryl Green; Isabelle Germano
Journal:  J Neurooncol       Date:  2019-10-16       Impact factor: 4.130

2.  Hearing Preservation after Low-dose Gamma Knife Radiosurgery of Vestibular Schwannomas.

Authors:  Ayako Horiba; Motohiro Hayashi; Mikhail Chernov; Takakazu Kawamata; Yoshikazu Okada
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-02-15       Impact factor: 1.742

3.  Long-term outcomes of rotating gamma knife for vestibular schwannoma: A 4-year prospective longitudinal study of 89 consecutive patients in Vietnam.

Authors:  Hung Dinh Kieu; Duong Ngoc Vuong; Khoa Trong Mai; Phuong Cam Pham; Tam Duc Le
Journal:  Surg Neurol Int       Date:  2021-11-30

4.  The new SRS/FSRT technique HyperArc for benign brain lesions: a dosimetric analysis.

Authors:  Hsiu-Wen Ho; Ching-Chieh Yang; Hsiu-Man Lin; Hsiao-Yun Chen; Chun-Chiao Huang; Shih-Chang Wang; Yu-Wei Lin
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.